- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03239197
Project SHARE (motherS Have All the Right microbEs)
December 8, 2017 updated by: Kimberly-Clark Corporation
An Exploratory Study to Evaluate the Transfer of the Maternal Microbial Consortia to Infants During and Following Birth
This is an exploratory study designed to collect microbial samples from several body locations from 6 pairs of mothers and their newborn infants at various time points.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Marshfield, Wisconsin, United States, 54449
- Marshfield Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
pregnant mothers and their infants, planning a vaginal birth and breastfeeding as primary source of nutrition
Description
Inclusion Criteria:
- Mother- pregnant female, singleton infant
- Infant- vaginal birth, breastfeeding as primary source of nutrition
Exclusion Criteria:
- Mother- antibiotic, steroid or antimicrobial use
- Infant- antibiotic, steroid or antimicrobial use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
mother infant pair
mother infant pair, singleton infant, vaginal birth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal staphylococci is transferred to infant during and following birth.
Time Frame: 6 weeks
|
presence of maternal staphylococci strain in infant
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joseph Welter, MD, Marshfield Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Johnson CL, Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics. 2012 May;129(5):950-60. doi: 10.1542/peds.2011-2736. Epub 2012 Apr 2.
- Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med. 2015 Feb;21(2):109-17. doi: 10.1016/j.molmed.2014.12.002. Epub 2014 Dec 11.
- Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009 Dec 18;326(5960):1694-7. doi: 10.1126/science.1177486. Epub 2009 Nov 5.
- Dowd SE, Sun Y, Wolcott RD, Domingo A, Carroll JA. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis. 2008 Aug;5(4):459-72. doi: 10.1089/fpd.2008.0107.
- Capone KA, Dowd SE, Stamatas GN, Nikolovski J. Diversity of the human skin microbiome early in life. J Invest Dermatol. 2011 Oct;131(10):2026-32. doi: 10.1038/jid.2011.168. Epub 2011 Jun 23.
- Madan JC, Farzan SF, Hibberd PL, Karagas MR. Normal neonatal microbiome variation in relation to environmental factors, infection and allergy. Curr Opin Pediatr. 2012 Dec;24(6):753-9. doi: 10.1097/MOP.0b013e32835a1ac8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 5, 2017
Primary Completion (Anticipated)
March 1, 2018
Study Completion (Anticipated)
December 1, 2018
Study Registration Dates
First Submitted
August 1, 2017
First Submitted That Met QC Criteria
August 2, 2017
First Posted (Actual)
August 3, 2017
Study Record Updates
Last Update Posted (Actual)
December 12, 2017
Last Update Submitted That Met QC Criteria
December 8, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 500-16-0004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microbiota
-
Microbio Co LtdCompleted
-
University of California, Los AngelesCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompleted
-
Manchester University NHS Foundation TrustUniversity of ManchesterRecruiting
-
University of ManitobaAlmond Board of CaliforniaTerminated
-
Afyonkarahisar Health Sciences UniversityNot yet recruiting
-
Third Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Hadassah Medical OrganizationBar-Ilan University, IsraelWithdrawn
-
Samara State Medical UniversityRecruitingOral MicrobiotaRussian Federation
-
Shanghai 10th People's HospitalRecruitingGut MicrobiotaChina